Schedule 13G ownership disclosure

Aviragen Therapeutics Inc

Security class unavailable · CUSIP: 053761102

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,292,061
Percent of class
5.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001609251-17-000002
Form type
SC 13G
Filer
Vaxart, Inc.
CIK
CIK 72444
Filed
Feb 14, 2017
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub